Treatment Options for Chronic Urticaria

Launched by SHEIKH ZAYED MEDICAL COLLEGE · Feb 7, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring two treatment options for chronic urticaria, a skin condition that causes hives and itching for more than six weeks. The study aims to compare the effectiveness of Autologous Serum Therapy (AST)—a treatment using the patient's own blood serum—with levocetirizine, a commonly used allergy medication. This research is important because chronic urticaria is a common issue that can significantly affect people's quality of life, and finding effective treatments is crucial.

To participate in this trial, you need to be between 13 and 60 years old and have been diagnosed with chronic urticaria for at least six weeks. Both men and women can join, but certain individuals, such as pregnant or breastfeeding women, those with weak immune systems, or those taking steroids recently, will not be eligible. If you qualify and choose to participate, you will be part of an important study that aims to find better ways to treat this condition. The trial is not yet recruiting participants, but it will provide an opportunity to help advance treatment options for chronic urticaria in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age: 13-60 years
• • Gender: Both male and female
• • Patients having urticaria for more than 6 weeks diagnosed clinically
• Exclusion Criteria:
• • Pregnancy and lactating females
• • Patients who are immunosuppressed either due to medication or disease.
• • Patients suffering from chronic diseases i-e chronic liver disease, chronic kidney disease.
• • Patients taking steroids in last 2 weeks.